Biotech Values

[drbio45]

I believe this was done more for the Irish domain to lower their effective tax rate than to get access to this drug.


jq1234 Thursday, 04/24/14 11:01:32 AM
Re: ghmm post# 177242
Post # of 177264

Bold move by CELG to expand its autoimmune/inflammation space: ORAL ASO drug!!! 7-day treatment, 100% clinical response, 80% clinical remission, small sample size, but I assume CELG had seen larger ph2 randomized placebo controlled trial result, could be a big drug. There must be multiple bidders to get to such high upfront.

GED0301 ph1 results:

www.nature.com/mt/journal/v20/n4/pdf/mt2011290a.pdf

http://www.ncbi.nlm.nih.gov/pubmed/22971085